Analysts Set Royalty Pharma plc (NASDAQ:RPRX) Target Price at $41.60
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received an average recommendation of “Buy” from the six analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. […]
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received an average recommendation of “Buy” from the six analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. […]
